Publikationen in Zusammenarbeit mit Forschern von University of Cagliari (14)

2020

  1. Modeling Parkinson’s disease neuropathology and symptoms by intranigral inoculation of preformed human α-synuclein oligomers

    International Journal of Molecular Sciences, Vol. 21, Núm. 22, pp. 1-25

2019

  1. Animal models of eating disorders

    Methods in Molecular Biology (Humana Press Inc.), pp. 297-314

  2. Brain activity of anandamide: a rewarding bliss?

    Acta Pharmacologica Sinica, Vol. 40, Núm. 3, pp. 309-323

  3. Impaired brain endocannabinoid tone in the activity-based model of anorexia nervosa

    International Journal of Eating Disorders, Vol. 52, Núm. 11, pp. 1251-1262

2018

  1. Cannabinoid signalling in the immature brain: Encephalopathies and neurodevelopmental disorders

    Biochemical Pharmacology, Vol. 157, pp. 85-96

  2. Limited access to a high fat diet alters endocannabinoid tone in female rats

    Frontiers in Neuroscience, Vol. 12, Núm. FEB

2017

  1. Cannabinoid CB1/CB2 receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity-based anorexia

    British Journal of Pharmacology, Vol. 174, Núm. 16, pp. 2682-2695

2016

  1. Adolescent Δ 9-Tetrahydrocannabinol Exposure Alters WIN55,212-2 Self-Administration in Adult Rats

    Neuropsychopharmacology, Vol. 41, Núm. 5, pp. 1416-1426

  2. Emotional profile of female rats showing binge eating behavior

    Physiology and Behavior, Vol. 163, pp. 136-143

  3. Summaries of plenary, symposia, and oral sessions at the XXII World Congress of Psychiatric Genetics, Copenhagen, Denmark, 12-16 October 2014

    Psychiatric Genetics, Vol. 26, Núm. 1, pp. 1-47

2015

  1. The endocannabinoid system: Anorexia nervosa and binge eating disorder

    Cannabinoids in Neurologic and Mental Disease (Elsevier Inc.), pp. 389-413

2013

  1. Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats

    British Journal of Pharmacology, Vol. 169, Núm. 4, pp. 820-833

2012

  1. Sativex-like combination of phytocannabinoids is neuroprotective in malonate-lesioned rats, an inflammatory model of Huntington's disease: Role of CB1 and CB2 receptors

    ACS Chemical Neuroscience

2011

  1. Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease

    Journal of Neuroscience Research, Vol. 89, Núm. 9, pp. 1509-1518